NEW YORK, Sept 27 – As genomics software company Genomica of Boulder Colo., gears up for an expected $85 million IPO this week, it said Wednesday that it had licensed its Discovery Manager software to Genome Therapeutics (Nasdaq: GENE).  

Financial terms of the agreement were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Magdalena Skipper, the incoming editor-in-chief of Nature, speaks with NPR's Weekend Edition Sunday.

Genetic genealogy has led to an arrest in another cold case, dating back to 1987.

In PLOS this week: mutation in second gene widens clinical symptoms of people with ADD3 mutations, comparative genomic analysis of Pseudovibrio, and more.

Wired reports that 23andMe is trying to bolster its outside collaborations.